This PDF is the current document as it appeared on Public Inspection on 05/13/2013 at 08:45 am.
Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Prescription Drug Product Labeling; Medication Guide Requirements” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, 301-796-7726, firstname.lastname@example.org.End Further Info End Preamble Start Supplemental Information
On April 30, 2012, the Agency submitted a proposed collection of information entitled “Prescription Drug Product Labeling; Medication Guide Requirements” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0393. The approval expires on January 31, 2016. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.Start Signature
Dated: May 8, 2013.
Assistant Commissioner for Policy.
[FR Doc. 2013-11364 Filed 5-13-13; 8:45 am]
BILLING CODE 4160-01-P